Serum Prostate-Specific Antigen as a Predictor of Prostate Volume in the Community: The Krimpen Study

European Urology

Volumn 51, Issue 6, 2007, Pages 1645-1653

  Bohnen, Arthur M ^a   Groeneveld, Frans P ^a   Bosch, J L H Ruud ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

BPH; Prostate volume; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NETHERLANDS; ORGAN SIZE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; ROC CURVE; TRANSRECTAL ULTRASONOGRAPHY; VOLUMETRY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; REGRESSION ANALYSIS; ROC CURVE;

EID: 34247344981     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.01.084     Document Type: Article

References (23)

1. Emberton M., et al. BPH: A progressive disease of aging men. Urology 61 (2003) 267-273
2. Lieber M.M., et al. Prostate volume and prostate-specific antigen in the absence of prostate cancer: a review of the relationship and prediction of long-term outcomes. Prostate 49 (2001) 208-212
3. Marberger M.J., et al. Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Eur Urol 38 (2000) 563-568
4. Boyle P., Gould A.L., and Roehrborn C.G. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomised clinical trials. Urology 48 (1996) 398-405
5. Anonymous. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 170 (2003) 530-547
6. Madersbacher S., Alivizatos G., Nordling J., Sanz C.R., Emberton M., and de la Rosette J.J.M.C.H. EAU 2004 guidelines on assessment, therapy, and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46 (2004) 547-554
7. Tong S., et al. Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 24 (1998) 673-681
8. Chenven E.S., et al. Evaluation of prostate volume by transrectal ultrasonography for use in a brachytherapy program. Urology 58 (2001) 753-757
9. Torp-Pedersen S., Juul N., and Jakobsen H. Transrectal prostatic ultrasonography. Equipment, normal findings, benign hyperplasia and cancer. Scand J Urol Nephrol 107 Suppl (1988) 19-25
10. Hendrikx A.J., et al. Ultrasonic determination of prostatic volume: a cadaver study. Urology 34 (1989) 123-125
11. Terris M.K., and Stamey T.A. Determination of prostate volume by transrectal ultrasound. J Urol 145 (1991) 984-987
12. Bangma C.H., et al. Transrectal ultrasonic volumetry of the prostate: in vivo comparison of different methods. Prostate 28 (1996) 107-110
13. Roehrborn C.G., et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology 49 (1997) 548-557
14. Roehrborn C.G., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53 (1999) 581-589
15. Blanker M.H., et al. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int 85 (2000) 665-671
16. Bosch J.L.H.R., Bohnen A.M., Groeneveld F.P., and Bernsen R. Validity of three calliper-based transrectal ultrasound methods and digital rectal examination in the estimation of prostate volume and its changes with age: the Krimpen study. Prostate 62 (2005) 353-363
17. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
18. Roehrborn C.G., et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology 53 (1999) 473-480
19. Roehrborn C.G., et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 163 (2000) 13-20
20. Roehrborn C.G. Accurate determination of prostate size via digital rectal examination and transrectal ultrasound. Urology 51 4A Suppl (1998) 19-22
21. Bosch J.L., et al. Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community. Urology 46 3 Suppl A (1995) 34-40
22. Mochtar C.A., Kiemeney L.A.L.M., van Riemsdijk M.M., et al. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Eur Urol 44 (2003) 695-700
23. Roehrborn C.G., Boyle P., Bergner D., et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. Urology 54 (1999) 662-669